-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
SARS-3CLpro-IN-1
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2409178-86-3.gif)
| Category | SARS-CoV |
| CAS | 2409178-86-3 |
| Description | SARS 3CLpro-IN-1 (Compound 3b) is a SARS 3CL protease inhibitor with an IC50 value of 95 μM, as a specific stereo isomer of the octahydroisochromene scaffold, directs the P1 site imidazole. |
Product Information
| Synonyms | SARS 3CLpro-IN-1|med.21724, Compound 54|CHEMBL4649013|BDBM429383|HY-150691|CS-0541865 |
| Molecular Weight | 390.56 |
| Molecular Formula | C22H38N4O2 |
| Canonical SMILES | CCCCN(C)CC1C2CCCCC2CC(O1)CNC(CC3=CN=CN3)C=O |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 464 |
| Exact Mass | 390.29947647 |
| In Vitro | SARS 3CLpro-IN-1 (Compound 3b) has high active (IC50=95 μM) and had a (1S, 3S)-configuration in the ring system |
| Target | IC50: 95 μM (SARS 3CL protease) |
| XLogP3-AA | 3.2 |
